Pub. Date : 2019 Nov 8
PMID : 31717403
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Crizotinib is an effective multi-target kinase inhibitor, approved against anaplastic lymphoma kinase (ALK)- or ROS proto-oncogene 1 (ROS-1)-positive non-small cell lung carcinoma (NSCLC); however, its application is accompanied by serious side effects. | Crizotinib | ROS proto-oncogene 1, receptor tyrosine kinase | Homo sapiens |